Transpact Enter. (542765)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Book value is positive at ₹9.47, so the balance sheet is not insolvent on reported numbers.
• Piotroski F-Score of 5/9 suggests a few basic financial-health signals are passing, not a 0-2 distress score.
• The latest quarter shows ₹0 Cr net profit rather than an outright loss, giving a zero base to improve from.
• If the 200% profit growth were to become repeatable, the PEG of 0.34 is optically attractive.

Concerns

• Latest quarter sales and net profit are both ₹0 Cr, leaving no operating earnings to value.
• ROE is -44.07% and ROCE is 0%, reflecting poor or negative returns on capital.
• P/B of 34.32 against book value ₹9.47 means the market price is far above tangible asset backing.
• Promoter holding and debt/equity are N/A, making governance and leverage assessment impossible.

AI Analysis

Let me start with what I know: this is a medical equipment company with a market capitalisation of just ₹13 crore and a share price of ₹325. The latest quarter shows sales of ₹0 crore and net profit of ₹0 crore. I cannot value a business that does not currently show revenue. Benjamin Graham said that ‘the investor’s chief problem—and even his worst enemy—is likely to be himself.’ My defence is discipline: I need a business that earns more than its cost of capital. Here return on equity is -44.07% and return on capital employed is 0.00%. That is not a wealth-creating machine; that is capital destruction. The reported profit growth of 200% and a PEG ratio of 0.34 look exciting in a broker’s note, but a 200% improvement from a barely-above-zero base is meaningless to me. The price-to-earnings ratio is 67.60, yet the latest quarter’s net profit is ₹0 crore. With book value of only ₹9.47 and price-to-book of 34.32, I am paying 34 times for assets, with no earnings to justify that premium. No dividend arrives while I wait. I also see 'N/A' for promoter holding and debt/equity. As an outside minority shareholder, I need honest and complete reporting; if I cannot see who owns the business and how much debt it has, I cannot trust my capital to it. The stock has moved from ₹119.55 to ₹325.00, but price movement is not a moat. A great business, in Graham’s language, is one where the owners can depend on earnings power. Here there is no sales growth, no revenue, and no recorded ROCE. If the company is truly at a turning point, the next few financial statements must show actual sales and positive operating profits. Until then, I will sit on my hands. In investing, a small company with zero revenue can be a lottery ticket, not an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer